Haemonetics · 2 days ago
Manager FP&A, NA Plasma
Haemonetics is a dynamic employer focused on adding core talent. The Plasma Finance Manager will lead financial processes for NA Plasma and Blood Center, providing analysis and support to assist in decision making and improve financial processes.
BiotechnologyConsultingHealth CareMedicalMedical Device
Responsibilities
Lead NA Plasma and Blood Center monthly business reviews, present results / forecast updates, and provide explanations for major drivers. Track status updates and facilitate discussion on milestones to meet strategic initiatives
Lead the development, analysis, and reporting of annual operating budgets, quarterly forecast process and long-range strategic financial plan for the North America Plasma and Blood Center business
Direct the financial planning and reporting for NA Plasma and Blood center business, including analyzing business trends by customer, reporting on share gain, volume and pricing trending on quarterly and monthly basis
Ensure accurate close on revenue and expense. Review journal entries and ensure revenue related adjustments are correctly reflected based on contracts. Review expenses and book journal entries as needed
Improve overall contract management process. Collaborate with contract, legal, sales operation and accounting team to ensure proper contract management across all systems and seek opportunities to automate and improve the process
Manage budget for supporting functions including headcount and variable expenses, provide support to business partners. Collaborate with cross functional team to ensure proper asset management
Report and track Key Performance Indicators (KPIs) and provide explanations for major drivers
Act as Finance 'Systems Expert' for Tableau and other AI Tools, lead creation & automation of business partner faced reports and improve other processes where possible
Lead special projects such as business development support, customer specific analysis, and requests as appropriate
Qualification
Required
Bachelors required
7+ years of progressive finance or accounting experience
Experience in building dashboards using business intelligence tools such as Tableau required
Experience with Salesforce (Revenue Cloud/CPQ/Spiff) required
Good knowledge of US GAAP
Must possess strong business analytical skills with thorough understanding of how to identify, interpret, and transform raw data sets into meaningful and actionable solutions
Demonstrated proficiency in using multiple data sources to draw inferences/conclusions and communicate those findings effectively
Drive for accuracy with excellent attention to detail
Ability to organize, prioritize, and deliver within tight deadlines
Strong problem-solving skills
Ability to think strategically coupled with working in a logical and structured way
Open and flexible attitude with the ability to execute tasks within deadlines
Excellent analytical, communication, and organizational skills required
Preferred
MBA/CPA preferred
Advanced knowledge of financial reporting systems (Hyperion/Oracle EPBCS preferred)
Benefits
401(k) with up to a 6% employer match and no vesting period
Employee stock purchase plan
Flexible time off for salaried employees
Accrual of three to five weeks’ vacation annually (based on tenure)
Accrual of up to 64 hours (annually) of paid sick time
Paid and/or floating holidays
Parental leave
Short- and long-term disability insurance
Tuition reimbursement
Health and welfare benefits
Company
Haemonetics
Haemonetics is a provider of blood and plasma supplies and services.
H1B Sponsorship
Haemonetics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (3)
2023 (3)
2022 (2)
2021 (4)
Funding
Current Stage
Public CompanyTotal Funding
$1.75B2024-05-21Post Ipo Debt· $600M
2021-03-01Post Ipo Equity· $435M
2019-05-23Post Ipo Equity· $10M
Leadership Team
Recent News
2026-01-03
2025-12-02
2025-11-21
Company data provided by crunchbase